BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:P-BCMA-ALLO1 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of P-BCMA-ALLO1\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04960579-3409@assetmemo.bio
DTSTAMP:20261121T005445Z
DTSTART;VALUE=DATE:20290331
DTEND;VALUE=DATE:20290401
SUMMARY:P-BCMA-ALLO1: Phase 1 readout est. (NCT04960579)
DESCRIPTION:P-BCMA-ALLO1\, phase 1\, Multiple Myeloma.\nStudy: P-BCMA-ALLO1
  Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
 \nEstimated primary completion: March 2029. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/p-bcma-allo1#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT04960579
URL:https://assetmemo.bio/drug/p-bcma-allo1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
